Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Geoff Birrell

University Name

Australia

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

50%

Pharmacotherapy

30%

Pharmacokinetic

30%

Malaria Research

30%

Pharmacometrics

20%

Drug Delivery

20%

Iron Metabolism

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles5

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study

Article Link

Year:

2022

Pyronaridine-Artesunate (Pyramax®) for the Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of Vietnam

Article Link

Year:

2021

In Vivo Efficacy and Pharmacokinetics of the 2-Aminomethylphenol Antimalarial JPC-3210 in the Aotus Monkey-Human Malaria Model

Article Link

Year:

2020

Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum

Article Link

Year:

2020

Pharmacokinetics and Ex Vivo Antimalarial Activity of Artesunate-Amodiaquine plus Methylene Blue in Healthy Volunteers

Article Link

Year:

2020

Collaborators1

Amanda De Paoli

Deakin University

AUSTRALIA

How do I reach out?

Meet Kite AI

Geoff Birrell

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles5

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study

Pyronaridine-Artesunate (Pyramax®) for the Treatment of Artemisinin- and Piperaquine-Resistant <i>Plasmodium falciparum</i> in the Central Highlands of Vietnam

In Vivo Efficacy and Pharmacokinetics of the 2-Aminomethylphenol Antimalarial JPC-3210 in the Aotus Monkey-Human Malaria Model

Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against <i>Plasmodium falciparum</i>

Pharmacokinetics and <i>Ex Vivo</i> Antimalarial Activity of Artesunate-Amodiaquine plus Methylene Blue in Healthy Volunteers

Collaborators1

Amanda De Paoli

How do I reach out?

Geoff Birrell

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles5

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study

Pyronaridine-Artesunate (Pyramax®) for the Treatment of Artemisinin- and Piperaquine-Resistant &lt;i&gt;Plasmodium falciparum&lt;/i&gt; in the Central Highlands of Vietnam

In Vivo Efficacy and Pharmacokinetics of the 2-Aminomethylphenol Antimalarial JPC-3210 in the Aotus Monkey-Human Malaria Model

Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against &lt;i&gt;Plasmodium falciparum&lt;/i&gt;

Pharmacokinetics and &lt;i&gt;Ex Vivo&lt;/i&gt; Antimalarial Activity of Artesunate-Amodiaquine plus Methylene Blue in Healthy Volunteers

Collaborators1

Amanda De Paoli

How do I reach out?

Pyronaridine-Artesunate (Pyramax®) for the Treatment of Artemisinin- and Piperaquine-Resistant <i>Plasmodium falciparum</i> in the Central Highlands of Vietnam

Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against <i>Plasmodium falciparum</i>

Pharmacokinetics and <i>Ex Vivo</i> Antimalarial Activity of Artesunate-Amodiaquine plus Methylene Blue in Healthy Volunteers